The first step in any effective medical treatment is an accurate diagnosis. Our mission is to raise the standards of health care delivery by enabling affordable, reliable and timely test results to the front lines of health care. AccSys Diagnostics has developed a portable point-of-care diagnostics device based on enzyme immunoassay technology that can accurately test for a variety of infectious diseases including Group A Strep, Influenza, HIV, Ebola, and Hepatitis. The instrument will enable health professionals around the world to obtain fast results and make treatment decisions before the patient leaves the clinic.
Our elite researchers, engineers, and developers utilize the latest scientific and technological advancements to produce incredibly accurate, cost effective, and easy-to-use diagnostic technology.
Our Technology Highlights
• Empowers local clinics with laboratory grade tests
• Low cost, compact and mobile
• Utilizes gold standard time proven technology
• Offers extensive menu of testable conditions
As a company largely focused on creating accessible technology, AccSys Diagnostics performs extensive medical and social research on the health care issues affecting numerous developing countries. In doing so, AccSys Diagnostics aims to produce non-exclusionary products capable of positively affecting the lives of millions, regardless of their location or economic standing.
AccSys Diagnostics is supported by “The Hatchery” and “The Creative Destruction Lab” at the University of Toronto.
http://hatchery.engineering.utoronto.ca/
Company’s Keywords:
medical diagnostics
<0
<
<
<2014